Clinical Trial Update: Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol

View source ↗

Summary

A completed clinical trial evaluating the hematologic toxicity of the TPF regimen (docetaxel, cisplatin, fluorouracil) in squamous cell carcinoma of the head an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Squamous Cell Head and Neck Carcinoma | Status: COMPLETED